个人中心 - 老虎社区

Zxtrades

IP属地：未知

帖子 · 6帖子 · 6
关注 · 0关注 · 0
粉丝 · 0粉丝 · 0

- ZxtradesZxtrades
  ·2021-06-18
  Nice
  非常抱歉，此主贴已删除
  429 评论
  点赞
  分享
  举报
- ZxtradesZxtrades
  ·2021-06-15
  Wow
  非常抱歉，此主贴已删除
  437 评论
  点赞
  分享
  举报
- ZxtradesZxtrades
  ·2021-06-15
  Oh
  Moderna Inks Partnership Deal with Tabuk Pharmaceuticals
  The pharmaceutical and biotechnology company Moderna, Inc. (MRNA) has collaborated with Tabuk Pharma
  Moderna Inks Partnership Deal with Tabuk Pharmaceuticals
  379 评论
  点赞
  分享
  举报
- ZxtradesZxtrades
  ·2021-06-15
  Oh
  非常抱歉，此主贴已删除
  791 评论
  点赞
  分享
  举报
- ZxtradesZxtrades
  ·2021-06-15
  Okay..
  非常抱歉，此主贴已删除
  446 评论
  点赞
  分享
  举报
- ZxtradesZxtrades
  ·2021-06-15
  Nice
  Toplines Before US Market Open on Monday
  U.S. stocks are seen opening marginally higher Monday, remaining near record levels, heading into a
  Toplines Before US Market Open on Monday
  658 评论
  点赞
  分享
  举报
暂无粉丝

热议股票

{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3573302279267798","uuid":"3573302279267798","gmtCreate":1610208255997,"gmtModify":1610208255997,"name":"Zxtrades","pinyin":"zxtrades","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":5,"tweetSize":6,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":3,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.01.25","exceedPercentage":"80.65%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.10.07","exceedPercentage":"80.86%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.06.01","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":3,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":168395076,"gmtCreate":1623949216495,"gmtModify":1634025337234,"author":{"id":"3573302279267798","authorId":"3573302279267798","name":"Zxtrades","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573302279267798","authorIdStr":"3573302279267798"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/168395076","repostId":"2144742672","repostType":4,"isVote":1,"tweetType":1,"viewCount":429,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":184133164,"gmtCreate":1623687665158,"gmtModify":1634030021284,"author":{"id":"3573302279267798","authorId":"3573302279267798","name":"Zxtrades","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573302279267798","authorIdStr":"3573302279267798"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/184133164","repostId":"2143738859","repostType":4,"isVote":1,"tweetType":1,"viewCount":437,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":184195665,"gmtCreate":1623687476957,"gmtModify":1634030025589,"author":{"id":"3573302279267798","authorId":"3573302279267798","name":"Zxtrades","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573302279267798","authorIdStr":"3573302279267798"},"themes":[],"htmlText":"Oh","listText":"Oh","text":"Oh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/184195665","repostId":"2143781157","repostType":4,"repost":{"id":"2143781157","kind":"news","pubTimestamp":1623660416,"share":"https://www.laohu8.com/m/news/2143781157?lang=&edition=full","pubTime":"2021-06-14 16:46","market":"us","language":"en","title":"Moderna Inks Partnership Deal with Tabuk Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2143781157","media":"SmarterAnalyst","summary":"The pharmaceutical and biotechnology company Moderna, Inc. (MRNA) has collaborated with Tabuk Pharma","content":"<p>The pharmaceutical and biotechnology company <a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a> (<b>MRNA</b>) has collaborated with Tabuk Pharmaceuticals to market its COVID-19 Vaccine and future, variant-specific booster candidates, in Saudi Arabia. Shares of the company declined 1.3% in Friday’s extended trading session.</p>\n<p>The financial terms of the deal have not been disclosed.</p>\n<p>Per the agreement, Tabuk could get the opportunity to distribute other authorized Moderna mRNA products in the future.</p>\n<p>Tabuk Pharmaceuticals, a fully-owned subsidiary of Astra Industrial Group, is a Saudi pharmaceuticals company.</p>\n<p>Moderna CEO Stephane Bancel said, “We appreciate the collaboration of Tabuk Pharmaceuticals in this new partnership in Saudi Arabia.”</p>\n<p>Bancel further added, “It is thanks to partnerships such as these that we are able to expand access to our vaccine globally, and we hope it will support the availability of our COVID-19 vaccine for the benefit of the people of Saudi Arabia.” (See&nbsp;Moderna stock analysis&nbsp;on TipRanks)</p>\n<p>On June 10, Brookline Capital Markets analyst&nbsp;Leah R. Cann&nbsp;reiterated a Buy rating on the stock but increased the price target to $224 (2.4% upside potential) from $205.</p>\n<p>Cann commented, “For a company at Moderna’s stage of development, which is largely pre-approval, we primarily focus on potential future revenue to value the company. Based on our expectation that in addition to its already launched COVID-19 vaccine, Moderna will launch several of its development-stage products in the next six years, we estimate that Moderna’s total revenue will increase to $100.1 billion in 2030.”</p>\n<p>The rest of the Street is cautiously optimistic about the stock with a Moderate Buy consensus rating based on 6 Buys, 3 Holds, and 2 Sells. The&nbsp;MRNA average analyst price target&nbsp;of $194 implies 11.4% downside potential to current levels. Shares have increased 41.1% over the past six months.</p>\n<p><img src=\"https://static.tigerbbs.com/a7b9b1c14597ff8c93148627f4cdbe23\" tg-width=\"825\" tg-height=\"286\" referrerpolicy=\"no-referrer\"></p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Inks Partnership Deal with Tabuk Pharmaceuticals</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Inks Partnership Deal with Tabuk Pharmaceuticals\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-14 16:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/moderna-inks-partnership-deal-tabuk-074356756.html><strong>SmarterAnalyst</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The pharmaceutical and biotechnology company Moderna, Inc. (MRNA) has collaborated with Tabuk Pharmaceuticals to market its COVID-19 Vaccine and future, variant-specific booster candidates, in Saudi ...</p>\n\n<a href=\"https://finance.yahoo.com/news/moderna-inks-partnership-deal-tabuk-074356756.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://finance.yahoo.com/news/moderna-inks-partnership-deal-tabuk-074356756.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2143781157","content_text":"The pharmaceutical and biotechnology company Moderna, Inc. (MRNA) has collaborated with Tabuk Pharmaceuticals to market its COVID-19 Vaccine and future, variant-specific booster candidates, in Saudi Arabia. Shares of the company declined 1.3% in Friday’s extended trading session.\nThe financial terms of the deal have not been disclosed.\nPer the agreement, Tabuk could get the opportunity to distribute other authorized Moderna mRNA products in the future.\nTabuk Pharmaceuticals, a fully-owned subsidiary of Astra Industrial Group, is a Saudi pharmaceuticals company.\nModerna CEO Stephane Bancel said, “We appreciate the collaboration of Tabuk Pharmaceuticals in this new partnership in Saudi Arabia.”\nBancel further added, “It is thanks to partnerships such as these that we are able to expand access to our vaccine globally, and we hope it will support the availability of our COVID-19 vaccine for the benefit of the people of Saudi Arabia.” (See Moderna stock analysis on TipRanks)\nOn June 10, Brookline Capital Markets analyst Leah R. Cann reiterated a Buy rating on the stock but increased the price target to $224 (2.4% upside potential) from $205.\nCann commented, “For a company at Moderna’s stage of development, which is largely pre-approval, we primarily focus on potential future revenue to value the company. Based on our expectation that in addition to its already launched COVID-19 vaccine, Moderna will launch several of its development-stage products in the next six years, we estimate that Moderna’s total revenue will increase to $100.1 billion in 2030.”\nThe rest of the Street is cautiously optimistic about the stock with a Moderate Buy consensus rating based on 6 Buys, 3 Holds, and 2 Sells. The MRNA average analyst price target of $194 implies 11.4% downside potential to current levels. Shares have increased 41.1% over the past six months.","news_type":1},"isVote":1,"tweetType":1,"viewCount":379,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":184195949,"gmtCreate":1623687467681,"gmtModify":1634030025948,"author":{"id":"3573302279267798","authorId":"3573302279267798","name":"Zxtrades","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573302279267798","authorIdStr":"3573302279267798"},"themes":[],"htmlText":"Oh","listText":"Oh","text":"Oh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/184195949","repostId":"1147529363","repostType":4,"isVote":1,"tweetType":1,"viewCount":791,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":184196115,"gmtCreate":1623687403837,"gmtModify":1634030027592,"author":{"id":"3573302279267798","authorId":"3573302279267798","name":"Zxtrades","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573302279267798","authorIdStr":"3573302279267798"},"themes":[],"htmlText":"Okay..","listText":"Okay..","text":"Okay..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/184196115","repostId":"2143781032","repostType":4,"isVote":1,"tweetType":1,"viewCount":446,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":184191595,"gmtCreate":1623687333217,"gmtModify":1634030028997,"author":{"id":"3573302279267798","authorId":"3573302279267798","name":"Zxtrades","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3573302279267798","authorIdStr":"3573302279267798"},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/184191595","repostId":"1172057691","repostType":4,"repost":{"id":"1172057691","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1623672122,"share":"https://www.laohu8.com/m/news/1172057691?lang=&edition=full","pubTime":"2021-06-14 20:02","market":"us","language":"en","title":"Toplines Before US Market Open on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1172057691","media":"Tiger Newspress","summary":"U.S. stocks are seen opening marginally higher Monday, remaining near record levels, heading into a ","content":"<p>U.S. stocks are seen opening marginally higher Monday, remaining near record levels, heading into a week that includes a keenly-awaited Federal Reserve meeting.</p>\n<p>At 7 AM ET (1200 GMT), the Dow futures contract was up just 5 points, or less than 0.1%, S&amp;P 500 futures traded 3 points, or 0.1%, higher, and Nasdaq 100 futures climbed 50 points, or 0.3%.</p>\n<p>The three major indices closed just higher Friday, with the broad-based S&amp;P 500 ending up 0.2%, at a new record high. The blue-chip Dow gained under 0.1% while the tech-heavy Nasdaq Composite closed 0.4% higher, helped by a rotation back into growth names.</p>\n<p>The Fed’s two-day policy meeting, ending Wednesday, will likely limit activity in the early part of the week. The central bank is not expected to take any immediate action, but investors will be focusing on the statement to see whether the policy makers open discussions about how and when to taper the $120 billion in monthly central bank bond purchases.</p>\n<p>Crude oil prices pushed higher Monday, trading near multi-year highs, helped by an improved outlook for demand as increased Covid-19 vaccinations push global travel back to near normalcy.</p>\n<p>U.S. daily air travelers have topped 2 million for the first time since the pandemic began with traffic returning to pre-pandemic levels in North America and much of Europe as lockdowns and other restrictions are being eased, although the U.K. could throw a spanner in the works later Monday.</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><b>Novavax(NVAX)</b> – The drugmaker said its Covid-19 vaccine proved 90% effective overall in a late-stage trial, and 93% effective against the most predominant variants of the virus. It also provided 100% protection against moderate and severe disease. Novavax shares surged 10.4% in premarket trading.</p>\n<p><b>Lordstown Motors(RIDE) </b>– The electric truck maker announced the resignation of CEO Steve Burns and CFO Julio Rodriguez, days after the company warned there was doubt it could continue as a going concern. Lordstown has engaged a search firm to find replacements for Burns and Rodriguez. Shares tumbled 8% in the premarket.</p>\n<p><b>Phillips(PHG)</b> – Phillips shares slid 4.3% in premarket action after saying it would recall up to 4 million CPAP machines due to potential toxicity risks. The foam used in the sleep apnea treatment devices could degrade and potentially become toxic. The Dutch medical equipment company is the largest producer of CPAP machines.</p>\n<p><b>Chipotle Mexican Grill(CMG)</b> – Raymond James upgraded the restaurant chain’s shares to “strong buy” from “outperform”, predicting that recent menu price increases would push second-half profit well beyond consensus forecasts. Chipotle shares gained 1.4% in the premarket.</p>\n<p><b>Ferrari(RACE)</b> – Goldman Sachs gave the automaker’s stock a double downgrade, moving its rating to “sell” from “buy”, noting increased capital spending and a limited scope for positive earnings revisions. Ferrari fell 2.7% in the premarket.</p>\n<p><b>GlaxoSmithKline(GSK)</b> – The drugmaker is collaborating with clinical-stage biopharmaceutical companyiTeos Therapeutics(ITOS) to develop and commercialize EOS-448, a monoclonal antibody in early-stage development as a possible cancer treatment. iTeos soared 60.4% in the premarket.</p>\n<p><b>AstraZeneca(AZN) </b>– The drugmaker’s Covid-19 vaccine has a favorable risk/reward profile for all age groups and particularly for those 60 years and older, according to the head of the European Medicines Agency’s Covid-19 task force. Marco Cavaleri said his quote in an Italian newspaper saying the vaccine should not be given to those over 60 was not interpreted correctly.</p>\n<p><b>Royal Dutch Shell(RDS.A)</b> – The energy giant is considering a sale of shale assets in Texas, according to people familiar with the matter who spoke to Reuters. Such a could be worth more than $10 billion. Shares gained 2% in premarket trading.</p>\n<p><b>Oatly(OTLY) </b>– The oat milk maker received a mixed batch of initial ratings from a handful of investment firms. Oatly received ratings of “perform” (Oppenheimer), “outperform” (Credit Suisse), “equal-weight” (Morgan Stanley), “overweight” (Piper Sandler), “buy” (Jefferies, Guggenheim), “neutral” (JPMorgan Chase) and “sector perform” (RBC Capital). All agree on growth prospects for Oatly – but some firms feel those prospects are already priced into the stock.</p>\n<p><b>Qualcomm(QCOM)</b> – Qualcomm is prepared to invest in UK chipmaker Arm if its $40 billion deal to be acquired byNvidia(NVDA) is blocked by regulators, according to the Telegraph newspaper quoting CEO Cristiano Amon.</p>\n<p><b>Equinix(EQIX)</b> – Equinix struck a deal for additional joint ventures with Singapore’s sovereign wealth fund to expand its data center operations there. The deal will see the fund invest an additional $3.9 billion, bringing the total investment to more than $6.9 billion.</p>\n<p><b>NextGen Acquisition(NGAC) </b>– The special purpose acquisition company is in advanced talks to take Sir Richard Branson’s Virgin Orbit public, according to Sky News. Sky said a deal valuing Virgin Orbit at about $3 billion could be announced within the coming weeks. NextGen shares gained 1.9% in the premarket.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-06-14 20:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stocks are seen opening marginally higher Monday, remaining near record levels, heading into a week that includes a keenly-awaited Federal Reserve meeting.</p>\n<p>At 7 AM ET (1200 GMT), the Dow futures contract was up just 5 points, or less than 0.1%, S&amp;P 500 futures traded 3 points, or 0.1%, higher, and Nasdaq 100 futures climbed 50 points, or 0.3%.</p>\n<p>The three major indices closed just higher Friday, with the broad-based S&amp;P 500 ending up 0.2%, at a new record high. The blue-chip Dow gained under 0.1% while the tech-heavy Nasdaq Composite closed 0.4% higher, helped by a rotation back into growth names.</p>\n<p>The Fed’s two-day policy meeting, ending Wednesday, will likely limit activity in the early part of the week. The central bank is not expected to take any immediate action, but investors will be focusing on the statement to see whether the policy makers open discussions about how and when to taper the $120 billion in monthly central bank bond purchases.</p>\n<p>Crude oil prices pushed higher Monday, trading near multi-year highs, helped by an improved outlook for demand as increased Covid-19 vaccinations push global travel back to near normalcy.</p>\n<p>U.S. daily air travelers have topped 2 million for the first time since the pandemic began with traffic returning to pre-pandemic levels in North America and much of Europe as lockdowns and other restrictions are being eased, although the U.K. could throw a spanner in the works later Monday.</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><b>Novavax(NVAX)</b> – The drugmaker said its Covid-19 vaccine proved 90% effective overall in a late-stage trial, and 93% effective against the most predominant variants of the virus. It also provided 100% protection against moderate and severe disease. Novavax shares surged 10.4% in premarket trading.</p>\n<p><b>Lordstown Motors(RIDE) </b>– The electric truck maker announced the resignation of CEO Steve Burns and CFO Julio Rodriguez, days after the company warned there was doubt it could continue as a going concern. Lordstown has engaged a search firm to find replacements for Burns and Rodriguez. Shares tumbled 8% in the premarket.</p>\n<p><b>Phillips(PHG)</b> – Phillips shares slid 4.3% in premarket action after saying it would recall up to 4 million CPAP machines due to potential toxicity risks. The foam used in the sleep apnea treatment devices could degrade and potentially become toxic. The Dutch medical equipment company is the largest producer of CPAP machines.</p>\n<p><b>Chipotle Mexican Grill(CMG)</b> – Raymond James upgraded the restaurant chain’s shares to “strong buy” from “outperform”, predicting that recent menu price increases would push second-half profit well beyond consensus forecasts. Chipotle shares gained 1.4% in the premarket.</p>\n<p><b>Ferrari(RACE)</b> – Goldman Sachs gave the automaker’s stock a double downgrade, moving its rating to “sell” from “buy”, noting increased capital spending and a limited scope for positive earnings revisions. Ferrari fell 2.7% in the premarket.</p>\n<p><b>GlaxoSmithKline(GSK)</b> – The drugmaker is collaborating with clinical-stage biopharmaceutical companyiTeos Therapeutics(ITOS) to develop and commercialize EOS-448, a monoclonal antibody in early-stage development as a possible cancer treatment. iTeos soared 60.4% in the premarket.</p>\n<p><b>AstraZeneca(AZN) </b>– The drugmaker’s Covid-19 vaccine has a favorable risk/reward profile for all age groups and particularly for those 60 years and older, according to the head of the European Medicines Agency’s Covid-19 task force. Marco Cavaleri said his quote in an Italian newspaper saying the vaccine should not be given to those over 60 was not interpreted correctly.</p>\n<p><b>Royal Dutch Shell(RDS.A)</b> – The energy giant is considering a sale of shale assets in Texas, according to people familiar with the matter who spoke to Reuters. Such a could be worth more than $10 billion. Shares gained 2% in premarket trading.</p>\n<p><b>Oatly(OTLY) </b>– The oat milk maker received a mixed batch of initial ratings from a handful of investment firms. Oatly received ratings of “perform” (Oppenheimer), “outperform” (Credit Suisse), “equal-weight” (Morgan Stanley), “overweight” (Piper Sandler), “buy” (Jefferies, Guggenheim), “neutral” (JPMorgan Chase) and “sector perform” (RBC Capital). All agree on growth prospects for Oatly – but some firms feel those prospects are already priced into the stock.</p>\n<p><b>Qualcomm(QCOM)</b> – Qualcomm is prepared to invest in UK chipmaker Arm if its $40 billion deal to be acquired byNvidia(NVDA) is blocked by regulators, according to the Telegraph newspaper quoting CEO Cristiano Amon.</p>\n<p><b>Equinix(EQIX)</b> – Equinix struck a deal for additional joint ventures with Singapore’s sovereign wealth fund to expand its data center operations there. The deal will see the fund invest an additional $3.9 billion, bringing the total investment to more than $6.9 billion.</p>\n<p><b>NextGen Acquisition(NGAC) </b>– The special purpose acquisition company is in advanced talks to take Sir Richard Branson’s Virgin Orbit public, according to Sky News. Sky said a deal valuing Virgin Orbit at about $3 billion could be announced within the coming weeks. NextGen shares gained 1.9% in the premarket.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","RACE":"法拉利","CMG":"墨式烧烤","AZN":"阿斯利康","QCOM":"高通","GSK":"葛兰素史克","RDS.A":"荷兰皇家壳牌石油A类股","OTLY":"Oatly Group AB","EQIX":"易昆尼克斯","PHG":"飞利浦"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1172057691","content_text":"U.S. stocks are seen opening marginally higher Monday, remaining near record levels, heading into a week that includes a keenly-awaited Federal Reserve meeting.\nAt 7 AM ET (1200 GMT), the Dow futures contract was up just 5 points, or less than 0.1%, S&P 500 futures traded 3 points, or 0.1%, higher, and Nasdaq 100 futures climbed 50 points, or 0.3%.\nThe three major indices closed just higher Friday, with the broad-based S&P 500 ending up 0.2%, at a new record high. The blue-chip Dow gained under 0.1% while the tech-heavy Nasdaq Composite closed 0.4% higher, helped by a rotation back into growth names.\nThe Fed’s two-day policy meeting, ending Wednesday, will likely limit activity in the early part of the week. The central bank is not expected to take any immediate action, but investors will be focusing on the statement to see whether the policy makers open discussions about how and when to taper the $120 billion in monthly central bank bond purchases.\nCrude oil prices pushed higher Monday, trading near multi-year highs, helped by an improved outlook for demand as increased Covid-19 vaccinations push global travel back to near normalcy.\nU.S. daily air travelers have topped 2 million for the first time since the pandemic began with traffic returning to pre-pandemic levels in North America and much of Europe as lockdowns and other restrictions are being eased, although the U.K. could throw a spanner in the works later Monday.\nStocks making the biggest moves in the premarket:\nNovavax(NVAX) – The drugmaker said its Covid-19 vaccine proved 90% effective overall in a late-stage trial, and 93% effective against the most predominant variants of the virus. It also provided 100% protection against moderate and severe disease. Novavax shares surged 10.4% in premarket trading.\nLordstown Motors(RIDE) – The electric truck maker announced the resignation of CEO Steve Burns and CFO Julio Rodriguez, days after the company warned there was doubt it could continue as a going concern. Lordstown has engaged a search firm to find replacements for Burns and Rodriguez. Shares tumbled 8% in the premarket.\nPhillips(PHG) – Phillips shares slid 4.3% in premarket action after saying it would recall up to 4 million CPAP machines due to potential toxicity risks. The foam used in the sleep apnea treatment devices could degrade and potentially become toxic. The Dutch medical equipment company is the largest producer of CPAP machines.\nChipotle Mexican Grill(CMG) – Raymond James upgraded the restaurant chain’s shares to “strong buy” from “outperform”, predicting that recent menu price increases would push second-half profit well beyond consensus forecasts. Chipotle shares gained 1.4% in the premarket.\nFerrari(RACE) – Goldman Sachs gave the automaker’s stock a double downgrade, moving its rating to “sell” from “buy”, noting increased capital spending and a limited scope for positive earnings revisions. Ferrari fell 2.7% in the premarket.\nGlaxoSmithKline(GSK) – The drugmaker is collaborating with clinical-stage biopharmaceutical companyiTeos Therapeutics(ITOS) to develop and commercialize EOS-448, a monoclonal antibody in early-stage development as a possible cancer treatment. iTeos soared 60.4% in the premarket.\nAstraZeneca(AZN) – The drugmaker’s Covid-19 vaccine has a favorable risk/reward profile for all age groups and particularly for those 60 years and older, according to the head of the European Medicines Agency’s Covid-19 task force. Marco Cavaleri said his quote in an Italian newspaper saying the vaccine should not be given to those over 60 was not interpreted correctly.\nRoyal Dutch Shell(RDS.A) – The energy giant is considering a sale of shale assets in Texas, according to people familiar with the matter who spoke to Reuters. Such a could be worth more than $10 billion. Shares gained 2% in premarket trading.\nOatly(OTLY) – The oat milk maker received a mixed batch of initial ratings from a handful of investment firms. Oatly received ratings of “perform” (Oppenheimer), “outperform” (Credit Suisse), “equal-weight” (Morgan Stanley), “overweight” (Piper Sandler), “buy” (Jefferies, Guggenheim), “neutral” (JPMorgan Chase) and “sector perform” (RBC Capital). All agree on growth prospects for Oatly – but some firms feel those prospects are already priced into the stock.\nQualcomm(QCOM) – Qualcomm is prepared to invest in UK chipmaker Arm if its $40 billion deal to be acquired byNvidia(NVDA) is blocked by regulators, according to the Telegraph newspaper quoting CEO Cristiano Amon.\nEquinix(EQIX) – Equinix struck a deal for additional joint ventures with Singapore’s sovereign wealth fund to expand its data center operations there. The deal will see the fund invest an additional $3.9 billion, bringing the total investment to more than $6.9 billion.\nNextGen Acquisition(NGAC) – The special purpose acquisition company is in advanced talks to take Sir Richard Branson’s Virgin Orbit public, according to Sky News. Sky said a deal valuing Virgin Orbit at about $3 billion could be announced within the coming weeks. NextGen shares gained 1.9% in the premarket.","news_type":1},"isVote":1,"tweetType":1,"viewCount":658,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"followers","isTTM":false}